Systemic Immune Activation and HIV Shedding in the Female Genital Tract

Journal of Acquired Immune Deficiency Syndromes

Volumn 71, Issue 2, 2016, Pages 155-162

  Spencer, Lashonda Y ^a   Christiansen, Shawna ^a   Wang, Chia Hao H ^a   Mack, Wendy J ^a   Young, Mary ^b   Strickler, Howard D ^c   Anastos, Kathryn ^c   Minkoff, Howard ^d   Cohen, Mardge ^e   Geenblatt, Ruth M ^f   Karim, Roksana ^a   Operskalski, Eva ^a   Frederick, Toni ^a   Homans, James D ^a   Landay, Alan ^g   Kovacs, Andrea ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e RUSH UNIVERSITY   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

HIV genital tract shedding; immune activation; T cell activation

Indexed keywords

CD38 ANTIGEN; VIRUS RNA;

ADULT; AGE; CANDIDIASIS; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHLAMYDIA; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONFERENCE PAPER; FEMALE; FEMALE GENITAL SYSTEM; GENITAL TRACT INFECTION; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; SYSTEMIC IMMUNE ACTIVATION; T LYMPHOCYTE ACTIVATION; VAGINA PH; VIRUS LOAD; VIRUS SHEDDING; BLOOD; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; ISOLATION AND PURIFICATION; LYMPHOCYTE ACTIVATION; MICROBIOLOGY; VIROLOGY;

ADULT; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; GENITALIA, FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; RNA, VIRAL; SEXUALLY TRANSMITTED DISEASES; VIRUS SHEDDING;

EID: 84955688910     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000823     Document Type: Conference Paper

References (34)

1. Kovacs A, Wasserman SS, Burns D, et al. Determinants of HIV-1 shedding in the genital tract of women. Lancet. 2001;358:1593-1601.
2. Khopkar P, Sane S, Bichare S, et al. Association of plasma viremia with HIV-1 RNA levels in cervicovaginal lavage secretions in HIV-1 seropositive ART naïve women from Pune, India. J Clin Virol. 2013; 58:730-732.
3. Natividad-Villanueva GU, Santiago GUE, Manalastas RM Jr, et al. Human immunodeficiency virus in plasma and cervicovaginal secretions in Filipino women. Int J STD AIDS. 2003;14:826-829.
4. Uvin SC, Caliendo AM. Cervicovaginal human immunodeficiency virus secretion and plasma viral load in human immunodeficiency virus-seropositive women. Obstet Gynecol. 1997;90:739-743.
5. Spinillo A, et al. Factors associated with nucleic acids related to human immunodeficiency virus type 1 in cervico-vaginal secretions. BJOG. 2001;108:634-641.
6. Debiaggi M, Zara F, Spinillo A, et al. Viral excretion in cervicovaginal secretions of HIV-1-infected women receiving antiretroviral therapy. Eur J Clin Microbiol Infect Dis. 2001;20:91-96.
7. Ghys PD, Fransen K, Diallo MO, et al. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immu-nosuppression in female sex workers in Abidjan, Côte d'Ivoire. AIDS. 1997;11:F85-F93.
8. Kreiss J, Willerford DM, Hensel M, et al. Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. J Infect Dis. 1994;170:1597-1601.
9. Kovacs A, Chan LS, Chen ZC, et al. HIV-1 RNA in plasma and genital tract secretions in women infected with HIV-1. J Acquir Immune Defic Syndr. 1999;22:124-131.
10. Borgdorff H, Tsivtsivadze E, Verhelst R, et al. Lactobacillus-dominated cervicovaginal microbiota associated with reduced HIV/STI prevalence and genital HIV viral load in African women. ISME J. 2014;8:1781-1793.
11. Cone RA. Vaginal microbiota and sexually transmitted infections that may influence transmission of cell-associated HIV. J Infect Dis. 2014; 210(suppl 3):S616-S621.
12. Graham SM, Holte SE, Peshu NM, et al. Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding. AIDS. 2007;21:501-507.
13. Fiore JR, Suligoi B, Saracino A, et al. Correlates of HIV-1 shedding in cervicovaginal secretions and effects of antiretroviral therapies. AIDS. 2003;17:2169-2176.
14. Barkan SE, Suligoi B, Saracino A, et al. The Women's interagency HIV study. WIHS collaborative study group. Epidemiology. 1998;9:117-125.
15. Nicholson J, Kidd P, Mandy F, et al. Three-color supplement to the NIAID DAIDS guideline for flow cytometric immunophenotyping. Cytometry. 1996;26:227-230.
16. Landay A, Benning L, Bremer J, et al. Correlates of immune activation marker changes in human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women who use illicit drugs. J Infect Dis. 2003;188:209-218.
17. Al-Harthi L, Voris J, Du W, et al. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells. J Infect Dis. 2006;193:1202-1210.
18. Kovacs A, Al-Harthi L, Christensen S, et al. CD8(+) T cell activation in women coinfected with human immunodeficiency virus type 1 and hepatitis C virus. J Infect Dis. 2008;197:1402-1407.
19. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991;29:297-301.
20. Palefsky JM, Minkoff H, Kalish LA, et al. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst. 1999; 91:226-236.
21. Homans J, Christensen S, Stiller T, et al. Permissive and protective factors associated with presence, level, and longitudinal pattern of cervicovaginal HIV shedding. J Acquir Immune Defic Syndr. 2012;60: 99-110.
22. Jaspan HB, Liebenberg L, Hanekom W, et al. Immune activation in the female genital tract during HIV infection predicts mucosal CD4 depletion and HIV shedding. J Infect Dis. 2011;204:1550-1556.
23. Wahl SM, Orenstein JM. Immune stimulation and HIV-1 viral replication. J Leukoc Biol. 1997;62:67-71.
24. Copeland KF, Heeney JL. T helper cell activation and human retroviral pathogenesis. Microbiol Rev. 1996;60:722-742.
25. Appay V, Sauce D. Immune activation and inflammation in HIV-1 infection: causes and consequences. J Pathol. 2008;214:231-241.
26. Giorgi JV, Liu Z, Hultin LE, et al. Elevated levels of CD38+ CD8+ T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. The Los Angeles Center, Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 1993; 6:904-912.
27. Giorgi JV, Hultin LE, McKeating JA, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis. 1999;179:859-870.
28. Benito JM, Zabay JM, Gil J, et al. Quantitative alterations of the functionally distinct subsets of CD4 and CD8 T lymphocytes in asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA, CD11b, CD38, HLA-DR, and CD25 antigens. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14:128-135.
29. Zara F, Nappi RE, Brerra R, et al. Markers of local immunity in cervico-vaginal secretions of HIV infected women: implications for HIV shedding. Sex Transm Infect. 2004;80:108-112.
30. Bull ME, Legard J, Tapia K, et al. HIV-1 shedding from the female genital tract is associated with increased Th1 cytokines/chemokines that maintain tissue homeostasis and proportions of CD8+FOXP3+ T cells. J Acquir Immune Defic Syndr. 2014;67:357-364.
31. Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006;12:1365-1371.
32. Brenchley JM, Douek DC. HIV infection and the gastrointestinal immune system. Mucosal Immunol. 2008;1:23-30.
33. Dandekar S. Pathogenesis of HIV in the gastrointestinal tract. Curr HIV/AIDS Rep. 2007;4:10-15.
34. Klebanoff SJ, Coombs RW. Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission. J Exp Med. 1991;174:289-292.